The global HEAD AND NECK CANCER DRUGS MARKET size is expected to be valued at USD 1.41 billion by 2022, as per a new report by Grand View Research, Inc., registering a CAGR of 9.4% during the forecast period. The market is expected to be collectively driven by the development of innovative and cost-effective treatments, numerous side... Continue Reading →